View recent announcements and news releases related to Providence ResearchTo read the full article, please click on the article title.
For Jenny Bailey, volunteering to participate in the study was an easy decision that she says she made for the sake of humanity. The 95-year-old, who has been living at Brock Fahrni for five years, received his first dose of the COVID-19 vaccine in early January and says he hopes his participation in the research study will help protect others.
The federal government announced more than $15 million for four community-based safer drug supply projects in B.C. this week in response to the ongoing overdose crisis, which has been worsened by the COVID-19 pandemic.
Practising self-care, taking time to grieve, learning more about the palliative approach – these are all strategies researchers have identified to help long-term care staff cope with death.
A pilot study has shown that an experimental vaccine can reduce the systemic immune response and symptoms of allergic rhinitis in individuals allergic to cats, including nasal congestion, sneezing, nasal itching and runny nose.
Congratulations to Dr. Anita Palepu for winning the 2020 Research and Mission Award. This annual award recognizes a scientist in our organization who demonstrates the mission and values of Providence Health Care while conducting outstanding research.
The Canada Research Continuity Emergency Fund (CRCEF) is a Tri-Agency program that is part of the Government of Canada's COVID-19 economic response plan. UBC is currently taking application for Stage 3 which supports maintenance and ramp-up costs incurred due to COVID-19.
As an affiliated institute with UBC, researchers should follow UBC's CRCEF Stage 3 application process to submit an application.
As the COVID-19 pandemic wears on, it has become clear that different age groups are experiencing the social and economic consequences of the virus in different ways.
Providence researchers are lending their research expertise and diagnostic know-how to support the WestJet-YVR COVID-19 Testing Study, a project sponsored by WestJet and Vancouver Airport Authority (YVR).
Atrial fibrillation patients do better with surgical procedure than drugs as initial treatment: study
New research led by a St. Paul’s Hospital cardiologist has found that a minimally invasive procedure provides longer-lasting benefits than drugs as the first course of treatment for this common heart condition.
A new study has found that rotating the swab after it’s inserted into the nose – a step that makes the procedure take longer, and may increase patient discomfort – does not improve the quality of the sample collected and is therefore unnecessary.